Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bio Essence (BIOE) Non Operating Income (2020 - 2025)

Bio Essence has reported Non Operating Income over the past 6 years, most recently at -$540.0 for Q4 2025.

  • Quarterly results put Non Operating Income at -$540.0 for Q4 2025, up 98.28% from a year ago — trailing twelve months through Dec 2025 was -$3014.0 (up 99.73% YoY), and the annual figure for FY2025 was -$3014.0, up 99.73%.
  • Non Operating Income for Q4 2025 was -$540.0 at Bio Essence, up from -$1255.0 in the prior quarter.
  • Over the last five years, Non Operating Income for BIOE hit a ceiling of $28842.0 in Q1 2024 and a floor of -$1.1 million in Q3 2024.
  • Median Non Operating Income over the past 5 years was -$957.5 (2025), compared with a mean of -$58712.6.
  • Biggest five-year swings in Non Operating Income: surged 8660.42% in 2022 and later plummeted 36703.01% in 2023.
  • Bio Essence's Non Operating Income stood at $48.0 in 2021, then surged by 8660.42% to $4205.0 in 2022, then soared by 195.55% to $12428.0 in 2023, then tumbled by 352.78% to -$31415.0 in 2024, then surged by 98.28% to -$540.0 in 2025.
  • The last three reported values for Non Operating Income were -$540.0 (Q4 2025), -$1255.0 (Q3 2025), and -$559.0 (Q2 2025) per Business Quant data.